| Literature DB >> 11165188 |
Abstract
Penetration through the blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (BCSFB) is necessary if a drug is to achieve the required concentration for a desired pharmacological effect. Efflux transport systems at the BBB and BCSFB provide a protective barrier function by removing drugs from the brain or cerebrospinal fluid and transferring them to the systemic circulation, respectively; several transporters at the BBB and BCSFB have been identified. Efflux transport should be taken into consideration during drug development to improve brain penetration and to avoid drug-drug interactions involving these transporters and subsequent side effects.Year: 2001 PMID: 11165188 DOI: 10.1016/s1359-6446(00)01632-9
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851